Cencora distributes pharmaceuticals, medical products, and related services to retail pharmacies, hospitals, health systems, and other providers throughout the United States and select international markets. It offers wholesale distribution of branded, generic, and specialty drugs along with services that help manufacturers bring products to market and support patient access and adherence. The company additionally provides animal health product distribution and supply chain solutions.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 80,663.5 | — | 687.4 | — |
| Q3 2025 | 83,728.6 | — | -339.7 | — |
| Q4 2025 | 85,932 | — | 559.6 | — |
| Q1 2026 | 78,355.9 | — | 1,641.3 | — |
| Q2 2026 | 84,754.8 | 5.1% | 763.5 | 11.1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Boston Scientific Corporation (BSX), TC Energy Corporation (TRP), United Rentals, Inc. (URI), MetLife, Inc. (MET), TransDigm Group Incorporated (TDG), Targa Resources Corp. (TRGP)